Breast Cancer Stage IV
2 competing products in clinical development for Breast Cancer Stage IV.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Datopotamab deruxtecan | Daiichi Sankyo | Phase 2 | Recruiting | 42 |
| Trastuzumab deruxtecan | Daiichi Sankyo | Phase 2 | Completed | 35 |